https://conferences.biocentury.com/bioequity-europe

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Discovery & Translation Analysis

Discovery & Translation

Hot Topics

BioCentury Podcasts 

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data Coverage

BCIQ Data

All Events

BioCentury's JPM Guide 2026

JPM Guide 2026

East-West Healthcare Reception

At the East-West Summit, you will meet key players looking to globalize innovation from across Asia.

East-West Biopharma Summit 2026

Bio€quity Europe

Grand Rounds — U.S.

Grand Rounds — Europe

China Healthcare Summit Inquiry

Podcast: The BioCentury Show

Podcast: BioCentury This Week

Webinars

Events

My Workspace

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Subscription

Sponsorship & Branding Inquiry

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Request a Trial

Contact

Home

Article

Editor's Commentary

2026 U.S. drug pricing outlook: ‘MFN’ is the future

Once unthinkable, pegging U.S. prices to international benchmarks will become routine

Politics, Policy & Law

Emerging Company Profile

Tolerance Bio: Rejuvenating the thymus

Starting with congenital athymia, former Provention Bio team aims to restore immune tolerance — with broader implications for lifespan extension

Podcast

Finance

JPM momentum and Asia’s hotbeds of innovation — a BioCentury podcast

Assessing the state of biotech at industry’s annual kickoff event